Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device

NACompletedINTERVENTIONAL
Enrollment

903

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

May 29, 2023

Study Completion Date

May 29, 2023

Conditions
COVID-19Influenza AInfluenza Type B
Interventions
DIAGNOSTIC_TEST

Panbio™

"The Panbio™ COVID-19/Flu A\&B Rapid Panel Professional use device is a visual lateral flow assay, for rapid immunochromatographic qualitative detection of COVID-19 antigen, Influenza A antigen and Influenza B antigen in nasopharyngeal swabs, collected by a trained health worker.~The Panbio™ COVID-19/Flu A\&B Rapid Panel Self-Test device is a visual lateral flow assay, for rapid immunochromatographic qualitative detection of COVID-19 antigen, Influenza A antigen and Influenza B antigen in self-collected mid-turbinate nasal swabs. The test is designed to be used by lay users"

Trial Locations (1)

29640

UCCT @ AFC Urgent Care- Easley, Easley

All Listed Sponsors
lead

Abbott Rapid Dx

INDUSTRY